Company Overview

Enovis Corporation (NYSE: ENOV) is a U.S.-based medical technology company focused on orthopedic and reconstructive care solutions. The company develops, manufactures, and markets products used in orthopedic reconstruction, surgical technologies, rehabilitation, pain management, and prevention. Enovis operates primarily within the global medical devices and healthcare technology industries, serving hospitals, ambulatory surgery centers, orthopedic surgeons, rehabilitation providers, and patients. Its core revenue drivers include reconstructive implant systems, orthopedic surgical technologies, and patient recovery products used across hip, knee, shoulder, foot, ankle, and spine-related procedures.

The company traces its roots to Colfax Corporation, an industrial manufacturing business founded in 1995. In 2022, Colfax officially rebranded as Enovis Corporation following the separation and sale of several industrial operations and a strategic transition toward becoming a pure-play medical technology company. A major catalyst in this transformation was the acquisition of DJO Global, which significantly expanded Enovis’ orthopedic and rehabilitation portfolio. The company positions itself around an “Intelligent Motion” strategy that integrates implants, surgical technologies, and recovery solutions intended to improve patient outcomes and procedural efficiency.

Business Operations

Enovis primarily operates through two major business segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment includes orthopedic bracing, rehabilitation equipment, recovery sciences, bone growth stimulation, and compression therapy products marketed under brands historically associated with DJO. The Reconstructive segment focuses on orthopedic implant systems and enabling technologies, including products for hip, knee, shoulder, foot, ankle, and surgical navigation applications. Revenue is generated through direct product sales, distributor relationships, and healthcare provider purchasing agreements across both domestic and international markets.

The company maintains manufacturing, research, and commercial operations across North America, Europe, Asia-Pacific, and select emerging markets. Enovis controls a portfolio of orthopedic implant technologies, digital surgical planning systems, and rehabilitation-focused product platforms. Strategic assets include advanced surgical enabling technologies and patient-specific procedural tools intended to support precision orthopedic care. The company has also maintained relationships with healthcare systems, orthopedic practices, and global distribution partners to expand market access and procedural adoption.

Strategic Position & Investments

Enovis has pursued a strategy centered on expanding its orthopedic reconstruction and surgical technology capabilities while integrating rehabilitation and recovery offerings into a unified patient-care ecosystem. The acquisition of DJO Global represented one of the company’s most significant strategic investments, materially increasing its exposure to higher-growth medical technology markets. Since the transition from Colfax, Enovis has emphasized portfolio optimization, operational integration, and targeted investment in orthopedic innovation.

The company has invested in digital surgery platforms, enabling technologies, and minimally invasive orthopedic solutions designed to improve workflow efficiency and patient outcomes. Enovis has also expanded its presence in foot and ankle reconstruction, shoulder systems, and surgical navigation technologies through acquisitions and internal development initiatives. Management has consistently highlighted innovation, surgeon engagement, and procedural differentiation as central pillars of long-term growth strategy. Public disclosures indicate continued focus on scalable global distribution and expansion in international orthopedic markets.

Geographic Footprint

Enovis is headquartered in Wilmington, Delaware, and maintains a significant operational footprint across the United States, Europe, Asia-Pacific, and parts of Latin America and the Middle East. The United States remains the company’s largest market, supported by extensive commercial operations and healthcare provider relationships. Internationally, the company markets orthopedic implants, recovery products, and rehabilitation technologies through direct sales organizations and distributor networks.

The company’s global manufacturing, distribution, and research capabilities support a diversified commercial presence across developed and emerging healthcare markets. Enovis has emphasized international expansion opportunities in orthopedic reconstruction and surgical technologies, particularly in regions experiencing increasing procedure volumes and aging populations. Its international operational structure also supports supply chain diversification and localized customer engagement strategies.

Leadership & Governance

Enovis is led by an executive team with backgrounds in medical technology, healthcare operations, industrial management, and orthopedic innovation. Following the transformation from Colfax into a medical technology-focused company, leadership has emphasized innovation-driven growth, disciplined capital allocation, and operational execution. The company’s governance structure reflects its evolution into a specialized orthopedic and rehabilitation technology business.

Key executives include:

• Matthew L. Trerotola – Chair of the Board and Chief Executive Officer
• Chris Hurlock – President and Chief Operating Officer
• Benjamin A. Berry – Executive Vice President and Chief Financial Officer
• Ashish Diwanji – Executive Vice President, General Counsel and Secretary
• Damian Smith – Group President, Reconstruction
• Brady Shirley – Group President, Prevention & Recovery

Leadership communications and public filings consistently emphasize a strategy focused on orthopedic innovation, global market expansion, disciplined acquisitions, and integration of procedural and recovery technologies across the continuum of musculoskeletal care.